(Q38413034)

2 September 2017

title

IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-κB. (English)

1 reference

2 September 2017

0 references

1 reference

Hongyu Guan

1

1 reference

2 September 2017

Heng Zhang

2

1 reference

2 September 2017

Junchao Cai

3

1 reference

2 September 2017

Jueheng Wu

4

1 reference

2 September 2017

Jie Yuan

5

1 reference

2 September 2017

Jun Li

6

1 reference

2 September 2017

Zhengsong Huang

7

1 reference

2 September 2017

Mengfeng Li

8

1 reference

2 September 2017

language of work or name

1 reference

23 November 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

223

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

436-445

1 reference

Malignant astrocytic glioma: genetics, biology, and paths to treatment

2 September 2017

cites work

1 reference

Combined radio- and chemotherapy of brain tumours in adult patients.

21 January 2018

1 reference

Anti-apoptosis mechanisms in malignant gliomas.

21 January 2018

1 reference

Targeting malignant glioma survival signalling to improve clinical outcomes.

21 January 2018

1 reference

Apoptosis as a novel target for cancer chemoprevention

21 January 2018

1 reference

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

21 January 2018

1 reference

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

NF-kappaB signaling pathway and its therapeutic implications in human diseases

21 January 2018

1 reference

Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas

21 January 2018

1 reference

Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.

21 January 2018

1 reference

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas

21 January 2018

1 reference

Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.

21 January 2018

1 reference

Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma

21 January 2018

1 reference

NF-kappaB controls growth of glioblastomas/astrocytomas

21 January 2018

1 reference

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential

21 January 2018

1 reference

NF-kappaB regulation: the nuclear response

21 January 2018

1 reference

21 January 2018

1 reference

IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex

21 January 2018

1 reference

NAK is an IkappaB kinase-activating kinase

21 January 2018

1 reference

Kinetic mechanisms of IkappaB-related kinases (IKK) inducible IKK and TBK-1 differ from IKK-1/IKK-2 heterodimer

21 January 2018

1 reference

Triggering the interferon antiviral response through an IKK-related pathway

21 January 2018

1 reference

Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes

21 January 2018

1 reference

IKKi/IKKϵ Plays a Key Role in Integrating Signals Induced by Pro-inflammatory Stimuli

21 January 2018

1 reference

Integrative genomic approaches identify IKBKE as a breast cancer oncogene

21 January 2018

1 reference

Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer

21 January 2018

1 reference

Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers

21 January 2018

1 reference

Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines

21 January 2018

1 reference

Enumeration of the simian virus 40 early region elements necessary for human cell transformation

21 January 2018

1 reference

Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival

21 January 2018

1 reference

Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-kappa B p50-p50 for the anti-apoptotic function of Bcl-2.

21 January 2018

1 reference

Endogenous inhibitors of nuclear factor-kB, an opportunity for cancer control

21 January 2018

1 reference

In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas

21 January 2018

1 reference

Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon

21 January 2018

1 reference

Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes.

21 January 2018

1 reference

Novel Molecular Targets in the Search for Anti-Inflammatory Agents

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2815

1 reference

2 September 2017

1 reference